Cargando…

A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection

To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianhua, Chen, Zeguo, Wang, Liheng, Feng, Sijia, Qiu, Qixuan, Chen, Dongdong, Li, Nianfeng, Xiao, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126887/
https://www.ncbi.nlm.nih.gov/pubmed/35606395
http://dx.doi.org/10.1038/s41598-022-12518-5
_version_ 1784712228023304192
author Wang, Jianhua
Chen, Zeguo
Wang, Liheng
Feng, Sijia
Qiu, Qixuan
Chen, Dongdong
Li, Nianfeng
Xiao, Yao
author_facet Wang, Jianhua
Chen, Zeguo
Wang, Liheng
Feng, Sijia
Qiu, Qixuan
Chen, Dongdong
Li, Nianfeng
Xiao, Yao
author_sort Wang, Jianhua
collection PubMed
description To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University from June 1, 2017 to June 1, 2019. According to the receiver operating characteristic (ROC) curve, the optimal cut-off value of inflammatory index and the TBS was determined by the Youden index. Prediction performance was compared by the area under the receiver operating characteristic curve (AUC). Cox regression analysis was used to determine the risk factors for the recurrence of HCC after liver resection. According to the independent risk factors of the patients, a prediction model for HCC was established based on inflammation index and tumor burden score (TBS).The prediction performance of the model was compared with single index (TBS group and NLR group) and traditional HCC stage models (TNM stage and BCLC stage). MLR = 0.39, NLR = 2.63, PLR = 134, SII = 428 and TBS = 8.06 are the optimal cut-off values. AUC of SII, PLR, NLR, MLR and TBS were 0.643, 0.642, 0.642, 0.618 and 0.724respectively. MVI (P = 0.005), satellite nodule (P = 0.017), BCLC B-C stage (P = 0.013), NLR > 2.63 (P = 0.013), TBS > 8.06 (P = 0.017) are independent risk factors for the recurrence of HCC after liver resection. According to this study, the optimal inflammatory index NLR combined with TBS was obtained. The AUC of NLR–TBS model was 0.762, not only better than NLR group (AUC = 0.630) and TBS group (AUC = 0.671), also better than traditional BCLC (AUC = 0.620) and TNM (AUC = 0.587) stage models. Interestingly, we found that NLR and TBS should be good prognostic factor for recurrence of HCC after liver resection. The NLR–TBS model based the best inflammatory index (NLR) and TBS have a better prediction performance and the prediction performance of NLR–TBS model not only better than NLR group and TBS group, but better than BCLC and TNM stage models.
format Online
Article
Text
id pubmed-9126887
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91268872022-05-25 A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection Wang, Jianhua Chen, Zeguo Wang, Liheng Feng, Sijia Qiu, Qixuan Chen, Dongdong Li, Nianfeng Xiao, Yao Sci Rep Article To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University from June 1, 2017 to June 1, 2019. According to the receiver operating characteristic (ROC) curve, the optimal cut-off value of inflammatory index and the TBS was determined by the Youden index. Prediction performance was compared by the area under the receiver operating characteristic curve (AUC). Cox regression analysis was used to determine the risk factors for the recurrence of HCC after liver resection. According to the independent risk factors of the patients, a prediction model for HCC was established based on inflammation index and tumor burden score (TBS).The prediction performance of the model was compared with single index (TBS group and NLR group) and traditional HCC stage models (TNM stage and BCLC stage). MLR = 0.39, NLR = 2.63, PLR = 134, SII = 428 and TBS = 8.06 are the optimal cut-off values. AUC of SII, PLR, NLR, MLR and TBS were 0.643, 0.642, 0.642, 0.618 and 0.724respectively. MVI (P = 0.005), satellite nodule (P = 0.017), BCLC B-C stage (P = 0.013), NLR > 2.63 (P = 0.013), TBS > 8.06 (P = 0.017) are independent risk factors for the recurrence of HCC after liver resection. According to this study, the optimal inflammatory index NLR combined with TBS was obtained. The AUC of NLR–TBS model was 0.762, not only better than NLR group (AUC = 0.630) and TBS group (AUC = 0.671), also better than traditional BCLC (AUC = 0.620) and TNM (AUC = 0.587) stage models. Interestingly, we found that NLR and TBS should be good prognostic factor for recurrence of HCC after liver resection. The NLR–TBS model based the best inflammatory index (NLR) and TBS have a better prediction performance and the prediction performance of NLR–TBS model not only better than NLR group and TBS group, but better than BCLC and TNM stage models. Nature Publishing Group UK 2022-05-23 /pmc/articles/PMC9126887/ /pubmed/35606395 http://dx.doi.org/10.1038/s41598-022-12518-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wang, Jianhua
Chen, Zeguo
Wang, Liheng
Feng, Sijia
Qiu, Qixuan
Chen, Dongdong
Li, Nianfeng
Xiao, Yao
A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title_full A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title_fullStr A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title_full_unstemmed A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title_short A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
title_sort new model based inflammatory index and tumor burden score (tbs) to predict the recurrence of hepatocellular carcinoma (hcc) after liver resection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126887/
https://www.ncbi.nlm.nih.gov/pubmed/35606395
http://dx.doi.org/10.1038/s41598-022-12518-5
work_keys_str_mv AT wangjianhua anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT chenzeguo anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT wangliheng anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT fengsijia anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT qiuqixuan anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT chendongdong anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT linianfeng anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT xiaoyao anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT wangjianhua newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT chenzeguo newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT wangliheng newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT fengsijia newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT qiuqixuan newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT chendongdong newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT linianfeng newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection
AT xiaoyao newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection